Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The omega-3 fatty acid pathway encompasses the metabolic and biosynthetic processes involved in the production, modification, and utilization of omega-3 polyunsaturated fatty acids (PUFAs), primarily alpha-linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA). This pathway is crucial for cell membrane structure, energy metabolism, signaling, and the synthesis of bioactive lipid mediators with anti-inflammatory properties. Dysregulation of this pathway is implicated in various diseases, including cardiovascular disease, inflammation, and neurological disorders.
N/A - Pathway itself is not a drug target, but components and downstream effects are.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Omega-3 Fatty Acid Pathway (N/A).